Sun Pharma’s facility listed under FDA import alert
Indian drugmaker Sun Pharmaceutical Industries, facility in western Gujarat state, has been listed by the Food & Drug Administration under "import alert," according.
Drugs
Pharma
Health
Medical
Pharma
US e-cigarette maker settles 5,000 lawsuits
Juul Labs, a US-based e-cigarette maker, announced that it had reached a settlement covering 5,000 lawsuits that accused the company of marketing to.
Drugs
Health
Pharma
Cambridge scientists develop repurposed liver drug to combat Covid-19
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.
Drugs
Pharma
Pfizer to invest $1.26 billion in Belgium plant in European expansion plan
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.
Drugs
Health
Pharma
Covid-19 virus leads to lung damage in UK patients after hospitalization
The Covid-19 virus, in some of the British patients discharged from hospitals, has led to lung damage which is irreversible and may get.
Drugs
Pharma
Israeli researchers develop artificially intelligent pathological assistants
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
Drugs
Health
Pharma
India’s drug regulator gives nod for world’s first nasal Covid-19 vaccine
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.
Drugs
Pharma
Alembic Pharmaceuticals gets FDA nod for diclofenac
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
Drugs
Pharma
FDA probing Prolia as study reveals ‘serious outcomes’
The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed “a substantial risk with.